The median age and the median CD4 count of patients with detectable VL (59% female) were 38 years and 211 cells/μL (14%), respectively, at enrolment; 64% were in WHO stage 3 or 4, 7% had a history of non-TB OIs and 19% had a history of TB. This evidence concerns the gene CD4 and tuberculosis.